Dictahan, Anastacia C.
HRN: 03-77-54 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2025
CIPROFLOXACIN 500MG (TAB)
05/04/2025
05/11/2025
PO
500 Mg
Q12 Hrs
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes